| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |